AAAAAA

   
Results: 1-17 |
Results: 17
VINORELBINE (VNR) PLUS 5-FLUOROURACIL CONTINUOUS-INFUSION (5-FU CI) IN PRETREATED ADVANCED BREAST-CANCER - ADRIA MEDICA GROUP
Authors: COBELLI S SCANNI A BATTELLI T PISONE A FRONTINI L DILULLO L MATTIOLI R
Citation: S. Cobelli et al., VINORELBINE (VNR) PLUS 5-FLUOROURACIL CONTINUOUS-INFUSION (5-FU CI) IN PRETREATED ADVANCED BREAST-CANCER - ADRIA MEDICA GROUP, European journal of cancer, 34, 1998, pp. 62-62
VINORELBINE(VNR) PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) - RESULTS OF A PHASE-III RANDOMIZED TRIAL
Authors: GRIDELLI C IANNIELLO GP MAIORINO L PIANTEDOSI V CIGOLARI S MANZIONE L FAILLA G ZUCCARINO L PEDICINI T VINANTE O CASTIGLIONE F CLERICI M BEARZ A DARWISH S ROSSI A MONFARDINI S GALLO C PERRONE F FRONTINI L
Citation: C. Gridelli et al., VINORELBINE(VNR) PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) - RESULTS OF A PHASE-III RANDOMIZED TRIAL, Annals of oncology, 9, 1998, pp. 408-408
GEMCITABINE PLUS VINORELBINE (GEMVIN) IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - SEQUENTIAL PHASE-I AND PHASE-II TRIALS
Authors: CIGOLARI S GRIDELLI C FRONTINI L GULISANO M ROBBIATI SF FARRIS A CLERICI M CASTIGLIONE F PIAZZA E IANNIELLO GP PERRONE F
Citation: S. Cigolari et al., GEMCITABINE PLUS VINORELBINE (GEMVIN) IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - SEQUENTIAL PHASE-I AND PHASE-II TRIALS, Annals of oncology, 9, 1998, pp. 419-419
VINORELBINE PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) -RESULTS OF A PHASE-III RANDOMIZED TRIAL
Authors: CLERICI M FRONTINI L IANNIELLO GP MAIORINO L PIANTEDOSI FV CIGOLARI S MANZIONE L FAILLA G ZUCCARINO L PEDICINI T VINANTE O CASTIGLIONE F BEARZ A TONATO M ROSSI A MONFARDINI S GALLO C PERRONE F GRIDELLI C
Citation: M. Clerici et al., VINORELBINE PLUS BEST SUPPORTIVE CARE (BSC) VS BSC IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) ELDERLY PATIENTS (PTS) -RESULTS OF A PHASE-III RANDOMIZED TRIAL, Annals of oncology, 9, 1998, pp. 64-64
INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD)
Authors: CASCINU S LABIANCA R GRAZIANO F PANCERA G BARNI S FRONTINI L LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPIDOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE-TRACT CANCER (GISCAD), British Journal of Cancer, 78(3), 1998, pp. 390-393
GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY
Authors: CASCINU S FRONTINI L LABIANCA R SILVA R FERRETTI B BARNI S CATALANO G CELLERINO R
Citation: S. Cascinu et al., GEMCITABINE (GEM) AND 5-FLUOROURACIL (5 FU) IN ADVANCED PANCREATIC-CANCER - A GISCAD PHASE-II STUDY, European journal of cancer, 33, 1997, pp. 1268-1268
HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY
Authors: LABIANCA R CASCINU S FRONTINI L BARNI S FIORENTINI G COMELLA G ZANIBONI A GOTTARDI O ARNOLDI E OLIANI C DURO M PAVANATO G MARTIGNONI G RAINA A PIAZZA E DALLAVALLE G VALSECCHI R PANCERA G LUPORINI G
Citation: R. Labianca et al., HIGH-DOSE VERSUS LOW-DOSE LEVO-LEUCOVORIN AS A MODULATOR OF 5-FLUOROACIL IN ADVANCED COLORECTAL-CANCER - A GISCAD PHASE-III STUDY, Annals of oncology, 8(2), 1997, pp. 169-174
BIOLOGICAL INDEXES PREDICTIVE OF SURVIVAL IN 519 ITALIAN TERMINALLY ILL CANCER-PATIENTS
Authors: MALTONI M PIROVANO M NANNI O MARINARI M INDELLI M GRAMAZIO A TERZOLI E LUZZANI M DEMARINIS F CARACENI A LABIANCA R SCARPI E INNOCENTI MP VINCI M CENTRONE G MARZOLA M GIACCON G ARNOLDI E GALLUCCI M FRONTINI L PIVA L ZANINETTA G PETRELLA V BARNI S BERETTA G CALIA C MORO G CARDAMONE I GROFF L AMADORI D
Citation: M. Maltoni et al., BIOLOGICAL INDEXES PREDICTIVE OF SURVIVAL IN 519 ITALIAN TERMINALLY ILL CANCER-PATIENTS, Journal of pain and symptom management, 13(1), 1997, pp. 1-9
INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER
Authors: CASCINU S LABIANCA R ALESSANDRONI P MARCELLINI M SILVA RR PANCERA G TESTA E MARTIGNONI G BARNI S FRONTINI L ZANIBONI A LUPORINI G CELLERINO R CATALANO G
Citation: S. Cascinu et al., INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN, GLUTATHIONE, AND FILGRASTIM - A REPORT FROM THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVETRACT CANCER, Journal of clinical oncology, 15(11), 1997, pp. 3313-3319
CISPLATIN-VINORELBINE COMBINATION CHEMOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: FRONTINI L CANDIDO P CATTANEO MT ZONATO S PIATTO E SCAPATICCI R ISA L RAINA A LANZETTI V PAVIA G LEGNANI W FILIPAZZI V RHO B PIAZZA E
Citation: L. Frontini et al., CISPLATIN-VINORELBINE COMBINATION CHEMOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER, Tumori, 82(1), 1996, pp. 57-60
ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY
Authors: ZANIBONI A LABIANCA R PANCERA G BARNI S FRONTINI L MARINI G LUPORINI G
Citation: A. Zaniboni et al., ORAL ETOPOSIDE AS 2ND-LINE CHEMOTHERAPY FOR COLORECTAL-CANCER - A GISCAD STUDY, Journal of chemotherapy, 7(3), 1995, pp. 246-248
L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD)
Authors: LABIANCA R CASCINU S BARNI S FIORENTINI G FRONTINI L COMELLA G ZANIBONI A DALLAVALLE G PANCERA G LUPORINI AC PESSI A LUPORINI G
Citation: R. Labianca et al., L-LEUCOVORIN (LLV) AS A MODULATOR OF 5-DAYS 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL-CANCER (ACC) - HIGH-DOSE (HD) VERSUS MW DOSE (LD), European journal of cancer, 31A, 1995, pp. 735-735
EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER
Authors: LABIANCA R MARSONI S PANCERA G TORRI V ZANIBONI A ERLICHMAN C PATER J SHEPHERD L ZEE B SEITZ JF MILAN C PIGNON JP AITINI E APOLONE G AUZZANI A BANDUCCI S BARNI S BERETTA GD BIFFI O BUCCI F CARDI G CIFATTE D COLUCCI G COMANDONE A COMELLA G CONFALONIERI C CONFU A COSTANZO M CRESPI C DAMIANI E DEGIORGI D DONGIOVANNI V FABRIS G FABRIZIO G FACENDOLA G FANTONI PA FERRAGNI A FIORI B FLORIANELLO F FRONTINI L GALLI E GARATTINI P GHERARDI G GIOVANELLI A GUILIANI F GOSSO P JANNIELLO GP KILDANI B LEO S LIBERATI A MAFFIONE G MAIELLO E MAIORINO L MANENTE P MARTIGNONI GC MARZOLA M MASTRODONATO M MERIGGI F MOLINARI B MOLINARI GF MONFERRONI N NASCIMBEN O NATALE C NEGRETTI S PALAZZO S PANVINI D PARISI V PEDICINI T PERADOTTO F PESSA S PIATTO E PIZZI G PROSPERI A PRUSCIANO F RABBI C RAINA A RUGGIERO A SAVA C SCANZI F CARRARO PS SMERIERI F STIVALA B TAIANA A TARDIO B TESTORE F TINAZZI A TURCATO G ZONATO S AYOUB J BELANGER K BIRON G BODURTHA AJ BOOS G BURNELL M CANO P CHARPENTIER D CHOW WSW CHRITCHLEY J CRIPPS C DANG SP DAVIS ML DAVIDSON M DINGLE B DRYER D FERLAND E FIELDS A FINE S JOLIVET J KAISER L KERR I KOCHA WI KOTWALL C KRIEGER H LEPINEMARTIN M LITTLE C LOFTERS WS MAHEU M MOORE M PRESSNAIL B RAGAZ J RAUNER H REZNICK R ROSS T ROTSTEIN L RUDINSKAS L SCHACTER B SHAH A SKILLINGS J STERN H TWEEDDALE M VANDENBERG T WALDE D WATT HJ WONG KWA YOSHIDA S BALDIT C BARONI JL BAZIN JP BEDENNE L BLANCHI A BOGNEL JC BOSSET JF BOUCHE O BRANDONE JM BRICOT R BURTIN P CADOR L CHARBIT M CHARLIER A COUROUBLE Y COUZIGOU P CUILLERET J DELPERO JR DUCREUX M DUMAS F ECHINARD E ETIENNE PL FRIGUET JL GIGNOUX M GIOVANNINI M HERR JP LAFON J LETREUT P LATRIVE JP LAUVAUX C LOUVET C MACKIEWICZ R MAUREL C MESSERSCHMITT C MORAND L MOREAU J MORIN T NORDLINGER B NOTERDAEME PM OLLIER JC PICAUD R PEINKOWSKI P PLACHOT JP PORTET R DUBATY HR ROUGIER P ROZENTAL G SASTRE B VOTTELAMBERT A WATRIN B ZEITOUN P
Citation: R. Labianca et al., EFFICACY OF ADJUVANT FLUOROURACIL AND FOLINIC ACID IN COLON-CANCER, Lancet, 345(8955), 1995, pp. 939-944
PREDICTION OF SURVIVAL OF PATIENTS TERMINALLY ILL WITH CANCER - RESULTS OF AN ITALIAN PROSPECTIVE MULTICENTRIC STUDY
Authors: MALTONI M PIROVANO M SCARPI E MARINARI M INDELLI M ARNOLDI E GALLUCCI M FRONTINI L PIVA L AMADORI D
Citation: M. Maltoni et al., PREDICTION OF SURVIVAL OF PATIENTS TERMINALLY ILL WITH CANCER - RESULTS OF AN ITALIAN PROSPECTIVE MULTICENTRIC STUDY, Cancer, 75(10), 1995, pp. 2613-2622
VINORELBINE IS AN ACTIVE ANTIPROLIFERATIVE AGENT IN PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY
Authors: GASPARINI G CAFFO O BARNI S FRONTINI L TESTOLIN A GUGLIELMI RB AMBROSINI G
Citation: G. Gasparini et al., VINORELBINE IS AN ACTIVE ANTIPROLIFERATIVE AGENT IN PRETREATED ADVANCED BREAST-CANCER PATIENTS - A PHASE-II STUDY, Journal of clinical oncology, 12(10), 1994, pp. 2094-2101
VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER
Authors: BARNI S ARDIZZOIA A BERNARDO G VILLA S STRADA MR CAZZANIGA M ARCHILI C FRONTINI L
Citation: S. Barni et al., VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER, Tumori, 80(4), 1994, pp. 280-282
VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER
Authors: BARNI S ARDIZZOIA A BERNARDO G VILLA S STRADA MR CAZZANIGA M ARCHILI C FRONTINI L
Citation: S. Barni et al., VINORELBINE AS SINGLE-AGENT IN PRETREATED PATIENTS WITH ADVANCED BREAST-CANCER, Tumori, 80(4), 1994, pp. 280-282
Risultati: 1-17 |